Jean Stimola-Sposaro, MSJ’s Post

Thrilled to announce an exciting collaboration with the incredible team at Lindus Health! 🎉 Together with Tasso, Inc., we are revolutionizing clinical trials by integrating Tasso's virtually painless remote blood collection technology. This partnership aims to significantly reduce patient burden and streamline the clinical trial process, enabling participants to collect blood samples from the comfort of their own homes. 🏡💉 By minimizing the need for lengthy study visits and eliminating travel requirements, we’re making it easier for patients to participate in trials, increasing reach and diversity, and reducing dropout rates. This innovative approach is expected to expedite patient recruitment and retention, ultimately accelerating the delivery of new treatments to those who need them most. Michael Young, Co-Founder of Lindus Health, perfectly sums up the impact: “Partnering with Tasso provides Lindus Health with a cutting-edge tool for remote blood collection, significantly expediting the clinical trial process. This collaboration enables us to design more flexible and patient-centric trials, ensuring greater convenience and participation. Together, we are accelerating the delivery of new treatments to patients, transforming the landscape of medical research.” Ben Casavant, PhD, CEO and Co-Founder of Tasso, adds: “Patients are at the heart of clinical trials. Making blood collection a better experience can bolster patient engagement, ultimately leading to trials that recruit and complete faster. We are pleased to partner with fellow innovator Lindus Health to accelerate life-saving clinical studies.” Together, we’re pioneering a more efficient, patient-friendly future for clinical research. 🌟 #ClinicalTrials #HealthcareInnovation #RemoteBloodCollection #PatientCentric #MedicalResearch #LindusHealth #Tasso https://lnkd.in/eY8Cbmwu

“The US leads the world in bringing new medical products to market, but the ability to generate evidence to inform clinical practice in postmarket settings needs improvement. Although a diverse group of stakeholders is working to improve postmarket evidence generation, the role of private payers has been underappreciated. Payers are crucial allies in improving evidence generation because better data would better inform coverage decisions, their policies and practices influence the conduct of care and research, and their claims data are a source of real-world evidence used in medical product evaluation. In addition, payers have a stake in improving evidence generation because the kinds of evidence needed to inform health care and coverage decisions are often not available when a product enters the market and may not be generated without their involvement. Here, we describe several key steps payers could take to improve evidence generation, including participating in efforts to reduce administrative and financial barriers to the conduct of clinical trials, directly incentivizing evidence generation on high-priority questions by funding potential cost-saving trials, increasing engagement with the medical products industry on evidentiary needs for coverage decisions, and improving usability of claims data by reducing data lags and routinely recording unique device identifiers. Broad payer engagement with US Food and Drug Administration recommendations regarding evidence generation will ensure that the opportunities to participate in clinical research are extended to all communities and that evidence needed to inform care is generated in trials and surveillance systems that reflect the clinical reality across the US. Increasing payer involvement in evidence generation can benefit all participants in the medical innovation ecosystem. The importance of payers in these efforts will continue to grow in response to imperatives to increase integration of care and research, engage a diverse set of communities in clinical research, and move toward alternative payment models.” #FDA #medtech #postmarketdata #paymentmodels

Transforming Patient Recruitment: The Hidden Link to Breakthrough Clinical Trial Success https://lnkd.in/ePw8iqe4 #Technology #ClinicalResearch #ClinicalTrials #PatientRecruitment #DigitalMarketing

An in-depth look at the strategies for boosting patient recruitment and retention in global studies is explored in this article from Applied Clinical Trials. With insights into the effective tactics being implemented, the piece underscores the role these strategies play in enhancing the scope and success of international #clinicalresearch. https://lnkd.in/e9AmvWbK

A study published today in the Journal of Circulation and presented at the #ACC2024 meeting by investigators from Mass General Brigham showcases the significant benefits of integrating personalized education on guideline-directed-medical-therapy adherence through remote monitoring. The findings show that patients who received education simultaneously with medication management demonstrated a higher rate of medication uptake and initiated treatment earlier compared to patients who received education over two months prior to medication management. Synchronyx's Tappt® Health technology is at the forefront of this innovation, employing a personalized remote therapeutic monitoring technology to capture real-time adherence data, patient-reported outcomes, and associated barriers to timely care. Tappt® Health not only supports medication adherence management but also actively engages patients in their care through targeted education and resources, empowering both patients and their care teams with the tools needed for success. Contact us today and start maximizing your patients' journey experience and outcomes through a comprehensive solution for remote monitoring, medication management, and personalized education. >> info@synchronyx.com https://lnkd.in/ehJh-gjf #remotemonitoring #GDMT #patienteducation #patientengagement #remotetherapeuticmonitoring #chroniccaremanagement #CCM #therapyinitiation

Patient and medical education are crucial in care delivery, becoming most effective when integrated into a coordinated team approach. More evidence confirms that remote monitoring presents a valuable opportunity to deliver this targeted education at just the right moment, ensuring the best possible outcomes for patients. #patienteducation #remotemonitoring #chroniccaremanagement

📢 New Insights: The Role of SDOH in Clinical Trials and Patient Outcomes 📢 We are excited to highlight a recent article, "The ABCs of SDOH: Meaningful Strategies to Improve Patient Outcomes," 🦖 The dinosaur age of ignoring social determinants of health (SDOH) is extinct, and we're at the forefront of integrating these crucial factors into clinical trial strategies! 🔬 Article Highlights: SDOH, such as financial strain, housing instability, and transportation barriers, are pivotal in influencing patient outcomes. Effective integration of SDOH data into clinical trial recruitment and real-world evidence strategies is becoming essential. Understanding and addressing SDOH can lead to more diverse and effective clinical trials, aligning with the FDA's diversity mandate. At Clinical Trial Scan, our innovative approaches align perfectly with these advancements: 🧬 SDOH Integration: We incorporate SDOH data into our patient recruitment strategies, ensuring that trials are inclusive and representative of diverse populations. 📈 Enhanced Targeting: Our advanced hyper-targeting algorithms and patient-centric methodologies help identify and recruit the right patients, overcoming barriers such as economic issues, travel constraints, and language differences. 📊 Impactful Outcomes: By leveraging real-world data and addressing SDOH factors, we ensure robust and reliable trial results, ultimately improving patient care and outcomes. Read the full article on the importance of SDOH in clinical trials here: https://lnkd.in/dFMsa6r7 Let's collaborate to elevate your clinical trials. Schedule a call with us today to discover how we can support your research and drive success by integrating SDOH into your strategies. 🚀: https://lnkd.in/e_7UZBmi #ClinicalTrials #PatientEngagement #MedicalResearch #HealthcareInnovation #ClinicalResearch #Pharma #Biotech #HealthTech #PatientRecruitment #PatientCentricity #DigitalHealth #SDOH #HealthEquity

Patient recruitment and retention are key elements that ensure trials are completed on time, are adequately powered to provide valid results, and maintain the integrity of the data collected. Unfortunately, these processes present significant challenges for researchers, and addressing them is essential for the overall success of clinical studies. Read more: https://bit.ly/4gHmGAj #ClinicalTrials #ClinicalResearch #PatientRetention

Recruitment challenges in clinical trials remain a significant hurdle, even after years of innovation. Competing trials, overburdened sites, and increasingly complex trial designs make patient enrollment a persistent challenge. This insightful article from Applied Clinical Trials explores strategies to improve patient recruitment outcomes, including leveraging real-world data, enhancing site engagement, and prioritizing diversity in trial populations. It emphasizes the importance of collaboration across stakeholders to address these longstanding issues. What resonates with me is how these challenges have persisted for so long, despite advances in technology and trial planning. Addressing them will require a focus on patient-centric strategies and smarter use of data to navigate competing trials and strained resources. What strategies or tools have you found effective in addressing these challenges? Let’s discuss! 👉 Read the article here: https://lnkd.in/g9FtYrba

Labcorp and Inspira Health have entered into a strategic collaboration. The lab services provider will manage the daily operations of the health system’s hospital laboratories in Vineland, Elmer, and Mullica Hill. Additionally, Labcorp will begin to serve as the primary lab for Inspira’s physician network. The new relationship combines important capabilities, experience and technologies from both organizations to enhance access to laboratory services and further the delivery of high-quality patient care. Labcorp will provide staffing, leadership, scientific knowledge, analytics, supply chain services and laboratory and technical support to Inspira’s inpatient hospital laboratories. Read more from Linda Lindner: